Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
25.06
+0.04 (0.16%)
At close: May 12, 2025, 4:00 PM
25.06
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Privia Health Group Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$27.57
Upside
+10.02%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Reiterates $29 | Buy | Reiterates | $29 | +15.72% | Apr 28, 2025 |
Baird | Baird | Buy Maintains $24 → $26 | Buy | Maintains | $24 → $26 | +3.75% | Apr 15, 2025 |
Barclays | Barclays | Hold Maintains $21 → $23 | Hold | Maintains | $21 → $23 | -8.22% | Apr 10, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $27 → $28 | Strong Buy | Maintains | $27 → $28 | +11.73% | Apr 10, 2025 |
Needham | Needham | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +19.71% | Apr 10, 2025 |
Needham | Needham | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +19.71% | Mar 21, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $26 → $29 | Buy | Maintains | $26 → $29 | +15.72% | Feb 28, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $29 → $30 | Strong Buy | Maintains | $29 → $30 | +19.71% | Feb 28, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $25 → $40 | Buy | Maintains | $25 → $40 | +59.62% | Feb 28, 2025 |
Needham | Needham | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +19.71% | Feb 28, 2025 |
JMP Securities | JMP Securities | Buy Maintains $26 | Buy | Maintains | $26 | +3.75% | Feb 14, 2025 |
Needham | Needham | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | -0.24% | Jan 15, 2025 |
Needham | Needham | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | -0.24% | Jan 10, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $26 | Buy | Reiterates | $26 | +3.75% | Jan 7, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $26 | Buy | Reiterates | $26 | +3.75% | Jan 2, 2025 |
Macquarie | Macquarie | Buy Initiates $25 | Buy | Initiates | $25 | -0.24% | Dec 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.